Maternal Mortality in Nigeria: Holding the Line in Uncertain Times. [PDF]
Dogbanya G.
europepmc +1 more source
What's new? Many countries are transitioning from cytology to human papillomavirus (HPV) testing as the primary cervical cancer screening test. This comprehensive evaluation of the second HPV screening round in CervicalScreen Norway among women returning 4–6 years after a first negative HPV test showed that their risk of testing positive was lower in ...
Tone Bjørge+5 more
wiley +1 more source
Author Correction: Causal relationship between inflammatory factors and gynecological cancer: a Bayesian Mendelian randomization study. [PDF]
Dang C+6 more
europepmc +1 more source
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner+7 more
wiley +1 more source
Expression of concern: Modified thermal balloon endometrial ablation in low resource settings: a cost-effective method using Foley's catheter. [PDF]
Helal AS+4 more
europepmc +1 more source
What's New? There have been increasing litigations against cervical screening programmes centred around cancer audits. This manuscript provides a comprehensive framework for conducting cancer audits in cervical screening programmes, addressing legal and ethical challenges, and ensuring effective outcomes.
Arunah Chandran+36 more
wiley +1 more source
Longer operative times but equally safe - a propensity score-matched analysis for laparoscopic procedures in women with early-stage (r-ASRM I-II) endometriosis performed by gynecology residents compared to attending surgeons. [PDF]
Schmidt MW+11 more
europepmc +1 more source
The transcription factor RIP140 regulates interferon γ signaling in breast cancer
What's New? Interferon γ (IFNγ) is a key player in breast cancer, with the potential to induce apoptosis and to shift tumors into a dormant state. However, it also may promote carcinogenesis and angiogenesis. In this study, transcriptomic analysis identified the transcription factor RIP140 as a key regulator of IFNγ signaling in breast cancer.
Stéphan Jalaguier+9 more
wiley +1 more source